期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Efficacy and safety of alcohol septal ablation in elderly patients:one-year outcome 被引量:1
1
作者 Hisham Dokainish Antoine Abchee +3 位作者 Ariel Delarosa Sherif F.Nagueh William Spencer nasser lakkis 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2005年第1期37-39,共3页
Objective The management of hypertrophic obstructive cardiomyopathy is not well-defined in the elderly.Medical therapy with 3-blockers and calcium-channel blockers are the mainstay therapy for symptomatic patients.Myo... Objective The management of hypertrophic obstructive cardiomyopathy is not well-defined in the elderly.Medical therapy with 3-blockers and calcium-channel blockers are the mainstay therapy for symptomatic patients.Myomectomy is usually reserved for patients who fail medical therapy. Alcohol septal ablation has been recently introduced as an alternative therapy. Patients and Methods Ninety-five patients older than 65 years of age were included. All patients have completed one year of follow-up. The mean age was 72 ± 5 years, 47 patients were females, 10 patients with history of hypertension. Results The mean rise in CK post alcohol ablation was 1052 ± 430IU. The mean NYHA class decreased from 2.9 ± 0.6 to 1.2 ± 0.5 ( P < 0.001 ). The exercise duration on treadmill testing increased from 328 ± 260 s to 349 ± 39 s. The mean resting left ventricular outflow tract gradient decreased from 65 ± 37 mmHg to 16 ± 29 mmHg at one year. One patient died in the hospital after coronary artery bypass grafting that was done subsequent to spiral dissection of the left anterior descending artery during ablation. Thirteen patients developed complete heart block immediately after ablation requiring pacing therapy. Conclusions Alcohol septal ablation seems to be an effective alternative therapeutic option for elderly patients with hypertrophic obstructive cardiomyopathy. Larger studies with longer follow-up are needed. 展开更多
关键词 HYPERTROPHY cardiomopathy ablation ALCOHOL
下载PDF
In-hospital outcome of elderly patients with acute coronary syndromes treated with platelet glycoproteinⅡb/Ⅲa blockers
2
作者 Julian Booker Hisham Dokainish nasser lakkis 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2005年第4期203-205,共3页
The safety of intravenous glycoprotein Ⅱb/Ⅲa inhibitors (GPI) in elderly patients admitted with acute coronary syndrome (ACS) has not yet been established. The purpose of this study was to evaluate the safety of GPI... The safety of intravenous glycoprotein Ⅱb/Ⅲa inhibitors (GPI) in elderly patients admitted with acute coronary syndrome (ACS) has not yet been established. The purpose of this study was to evaluate the safety of GPI in elderly patients with ACS. Methods Ninety consecutive patients ≥70 years of age admitted to a county hospital between 1999-2004 were included. All patients had typical ACS symptoms along with high-risk markers. Results There was no difference in the TIMI risk score between patients who received GPI (n=47) and those who did not (n=43). Patients who received GPI had a lower creatinine clearance(40 cc/min vs. 47cc/min, p= 0.04). Patients who received GPI had a lower incidence of death, reinfarction or major bleeding (19% vs.4%, p=0.03). There was no significant difference in major bleeding between the 2 groups. None of the patients in either group developed thrombocytopenia. Conclusion This retrospective small study suggests that the use of GPI in a selected group of elderly patients with acute coronary syndrome may be safe. 展开更多
关键词 acute CORONARY SYNDROMES ANTIPLATELET therapy elderly BLEEDING
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部